Ornithine as a possible marker of cancer.
The nonprotein amino acid ornithine is the major source of polyamines in mammalian physiological systems. Increased urinary polyamine levels have been demonstrated in humans with varied types of cancers. The metabolism of DL-[1-14C]ornithine monohydrochloride in rats with either Walker 256 carcinoma or chemically induced methylcholanthrene tumors was studied. Following the i.p. injection of 3 muCi[14C]ornithine per 100 g body weight, the decarboxylation of ornithine-yielding 14CO2 was monitored by utilizing the vibrating reed electrometer-ionization chamber model of Davidson and Schwabe. Tumor-bearing animals showed significant increases in ornithine metabolism as compared to controls; for Walker 256 the tumor-bearing animal to control ratio rose from 1.16 to 1.78, for methylcholanthrene implants it rose from 1.19 to 1.82, and for methylcholanthrene paintings it rose from 1.00 to 2.20. With tumor regression ornithine levels of metabolism in the tumor-bearing animals returned to base line or nearly base-line levels. These results encourage us in our attempt to develop ornithine as a biological marker of cancer.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000378:metabolism*; D003653:Decarboxylation; D005260:Female; D008748:Methylcholanthrene / Q000008:administration & dosage; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism*; D009952:Ornithine / Q000378:metabolism*; D051381:Rats; D012075:Remission, Spontaneous
D008748:Methylcholanthrene; D009952:Ornithine